 | | PRD_001097 | | Name: | Trypsin inhibitor 1 | | Formula: | C67 H106 N18 O18 S2 | | Definition date: | 2014-04-23 | | Last modified: | 2014-04-23 |
|
 | | PRD_000973 | | Name: | Trypsin inhibitor 1 | | Formula: | C71 H103 N18 O18 S2 | | Definition date: | 2014-04-09 | | Last modified: | 2014-04-09 |
|
 | | PRD_001086 | | Name: | Microviridin J | | Formula: | C80 H108 N19 O22 | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_001218 | | Name: | Dityromycin | | Formula: | C67 H88 N10 O16 | | Description: | DITYROMYCIN WAS CLARIFIED TO BE COMPOSED OF N-MEVAL, PRO, VAL, PHENYLGLYCINE, CH3NH2, N,N-ME2THR AND DI-ALPHA-AMINO ACID CONTAINING DIPHENYLETHER MOIETY. | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_001219 | | Name: | Lantibiotic 107891 | | Formula: | C94 H127 Cl N26 O26 S5 | | Description: | NAI-107 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR. | | Definition date: | 2014-03-05 | | Last modified: | 2014-03-05 |
|
 | | PRD_001104 | | Name: | cyclic peptide S2iL5 | | Formula: | C90 H126 F3 N27 O23 S | | Definition date: | 2014-02-19 | | Last modified: | 2014-02-19 |
|
 | | PRD_001166 | | Name: | bicyclic peptide UK749 | | Formula: | C71 H108 N25 O20 S3 | | Definition date: | 2014-02-05 | | Last modified: | 2014-02-05 |
|
 | | PRD_001130 | | Name: | SmBz, cyclosporin A derivative | | Formula: | C70 H118 N11 O14 | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_001187 | | Name: | pGly[807,811], a stapled myoA tail peptide | | Formula: | C98 H177 N31 O23 S | | Definition date: | 2013-11-06 | | Last modified: | 2013-11-06 |
|
 | | PRD_001063 | | Name: | Beta-Hairpin Peptidomimetic antibiotic TWL(DAB)(ORN)(DLY)RW(ORN)(DAB)AK(DPR)P | | Formula: | C81 H131 N25 O15 | | Definition date: | 2013-09-11 | | Last modified: | 2013-09-11 |
|
 | | PRD_000874 | | Name: | PawS Derived Peptide 4 (PDP-4) | | Formula: | C59 H82 N18 O15 S2 | | Definition date: | 2013-08-21 | | Last modified: | 2013-08-21 |
|
 | | PRD_000875 | | Name: | PawS Derived Peptide 7 (PDP-7) | | Formula: | C65 H106 N20 O20 S2 | | Definition date: | 2013-08-21 | | Last modified: | 2013-08-21 |
|
 | | PRD_001122 | | Name: | CYCLOSPORIN D | | Formula: | C64 H115 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | | Definition date: | 2013-06-20 | | Last modified: | 2013-06-20 |
|
 | | PRD_000899 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C53 H67 N7 O11 S | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000960 | | Name: | N-[(benzyloxy)carbonyl]-L-valyl-L-alpha-glutamyl-N-[(2R)-1-carboxy-3-oxo-4-(2,3,5,6-tetrafluorophenoxy)butan-2-yl]-L-isoleucinamide | | Formula: | C35 H42 F4 N4 O11 | | Definition date: | 2013-03-20 | | Last modified: | 2013-06-03 |
|
 | | PRD_000966 | | Name: | [(5S)-5-[[(2S)-6-azaniumyl-2-[[(2S)-6-azaniumyl-2-[2-[[(2S)-2-[[(2S)-2-[[(2S,5S,8S,11S,20S)-20-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-azanyl-3-methyl-pentanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-phenyl-propanoyl]amino]-2-(2-hydroxy-2-oxoethyl)-11,20-dimethyl-5,8-bis(2-methylpropyl)-3,6,9,21-tetrakis(oxidanylidene)-1,4,7,10-tetrazacyclohenicos-11-yl]carbonylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]ethanoylamino]hexanoyl]amino]hexanoyl]amino]-6-oxidanyl-6-oxidanylidene-hexyl]azanium | | Formula: | C87 H140 N17 O20 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000989 | | Name: | ISOAMYLPHOSPHONYL-GLY-PRO-ALA | | Formula: | C15 H28 N3 O6 P | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_001002 | | Name: | [Aba3,7,12,16]BTD-2 | | Formula: | C82 H156 N36 O18 S2 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_001006 | | Name: | [Aba5,7,12,14]BTD-2 | | Formula: | C82 H156 N36 O18 S2 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_001009 | | Name: | [Aba3,5,7,12,14,16]BTD-2 | | Formula: | C84 H162 N36 O18 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_001039 | | Name: | BICYCLIC PEPTIDE INHIBITOR UK504 | | Formula: | C55 H94 N23 O16 S4 | | Definition date: | 2013-05-15 | | Last modified: | 2013-06-03 |
|
 | | PRD_001091 | | Name: | monomeric peptide inhibitor | | Formula: | C72 H103 N19 O16 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000816 | | Name: | DIMERIC PEPTIDE INHIBITOR | | Formula: | C78 H116 N21 O17 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000817 | | Name: | LEDGF peptide | | Formula: | C36 H61 N10 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000818 | | Name: | ALKIDNLD peptide | | Formula: | C39 H67 N10 O13 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
